Jianhuang Lin
ORCID: 0000-0002-0035-0938Also affiliated with GlaxoSmithKline (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 11 papers. Top paper: “EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition”.
Takeshi Fukumoto, Bo Zhao, Jianhuang Lin, Shuai Wu, Nail Fatkhutdinov +9 more
Pingyu Liu, Takeshi Fukumoto, Timothy Nacarelli, Nail Fatkhutdinov, Shuai Wu +7 more
Fuming Li, Jianhuang Lin, Takeshi Fukumoto, Timothy Nacarelli, Xue Hao +4 more
Takeshi Fukumoto, Jianhuang Lin, Timothy Nacarelli, Yemin Wang, Dionzie Ong +16 more
Dajiang Guo, Heng Liu, Wei Zhou, Chen Wang, Iris Müller +6 more
Heng Liu, Takeshi Fukumoto, Joseph A. Zundell, Qingqing Yan, Chih-Hang Anthony Tang +9 more
Takeshi Fukumoto, Jianhuang Lin, Nail Fatkhudinov, Timothy Nacarelli, Andrew V. Kossenkov +6 more
Jianhuang Lin, Wei Zhou, Renyta Moses, Zhongping Dai, Andrew V. Kossenkov +5 more
Heng Liu, Zhe Yuan, Joseph A. Zundell, Martina Towers, Jianhuang Lin +16 more
Aaron R. Goldman, Hsin‐Yao Tang, Andrew V. Kossenkov, Heng Liu, Wei Zhou +4 more
Takeshi Fukumoto, Jianhuang Lin, Nail Fatkhudinov, Timothy Nacarelli, Andrew V. Kossenkov +6 more